⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18469863 | 0.80 | — | — | |
| SCHEMBL14431689 | 0.78 | — | — | |
| SCHEMBL10531759 | 0.78 | — | — | |
| SCHEMBL4843604 | 0.78 | — | — | |
| SCHEMBL2642510 | 0.78 | — | — | |
| Isophthalic Acid SCHEMBL27816983 | 0.77 | RAB9A (0.58) | — | |
| Hydrochloric Acid SCHEMBL7036884 | 0.76 | — | — | |
| SCHEMBL2777930 | 0.75 | FDPS (0.58) | — | |
| SCHEMBL8302977 | 0.75 | — | — | |
| SCHEMBL13665441 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118871112-A | Use of 4-thiazol-N- (pyridin-2-yl) pyrimidin-2-amine derivatives in cancer combination therapy | 澳升医药公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118843465-A | Use of 5- (2- ((5- (4- (dimethylamino) piperidin-1-yl) pyridin-2-yl) amino) -5-fluoropyrimidin-4-yl) -N, 4-dimethylthiazol-2-amine in cancer combination therapy | 澳升医药公司 | 2024-10-25 | — | — | CN | claimed |
| EP-4146201-A1 | TREATMENT OF PROLIFERATIVE DISEASES OF THE CNS | Aucentra Therapeutics Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| CN-115666561-A | Treatment of proliferative diseases of the CNS | 澳升医药公司 | 2023-01-31 | — | — | CN | claimed |
| WO-2021222967-A1 | TREATMENT OF PROLIFERATIVE DISEASES OF THE CNS | AUCENTRA THERAPEUTICS PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| CN-109053623-B | Preparation method of 4-methyl-5-thiazole formaldehyde | 济南悟通生物科技有限公司 | 2020-08-04 | — | — | CN | claimed |
| CN-109053623-A | A kind of novel processing step of 4- methyl-5-thiazole formaldehyde | 济南悟通生物科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| US-5693619-A | ENZYME INHIBITORS; ADMINISTERED TO TREAT CONGESTIVE HEART FAILURE AND HYPERTENSION | BOEHRINGER INGELHEIM (CANADA), LTD. (CA) | 1997-12-02 | — | — | US | claimed |
| EP-0589446-B1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BOEHRINGER INGELHEIM CA LTD (CA) | 1997-09-03 | — | — | EP | claimed |
| EP-0589445-B1 | Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1997-01-15 | — | — | EP | claimed |
| US-5565476-A | RENIN INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND HYPERTENSION | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-10-15 | — | — | US | claimed |
| US-5554634-A | HYPOTENSIVE | BIO-MEGA BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-09-10 | — | — | US | claimed |
| US-5541163-A | HYPOTENSIVE AGENTS | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-07-30 | — | — | US | claimed |
| US-5523315-A | N-(hydroxyethyl)butanediamide derivatives | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-06-04 | — | — | US | claimed |
| WO-1994007846-A1 | RENIN INHIBITING N-(2-AMINO-2-OXOETHYL)BUTANEDIAMIDE DERIVATIVES | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-04-14 | — | — | WO | claimed |
| WO-1994007845-A1 | N-(HYDROXYETHYL)BUTANEDIAMIDE DERIVATIVES AS RENIN INHIBITORS | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-04-14 | — | — | WO | claimed |
| EP-0589445-A1 | Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-03-30 | — | — | EP | claimed |
| EP-0589446-A1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-03-30 | — | — | EP | claimed |
| US-12404270-B2 | Quinazoline derivatives as LPA receptor 2 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-09-02 | — | — | US | disclosed |
| EP-0589445-A1 | Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-03-30 | — | — | EP | disclosed |